M Frumovitz
Papers
1
Total Citations
15
H-Index
1
About
Dr. M. Frumovitz is a leading gynecologic oncologist and researcher whose work has fundamentally advanced the surgical management of early-stage cervical cancer. Her primary research focus is on de-escalating treatment to preserve fertility and reduce morbidity without compromising oncologic outcomes. Her most notable contribution is the landmark "Concerv" trial (2019), a prospective study that demonstrated the safety and efficacy of conservative, fertility-sparing surgery for patients with low-risk, early-stage cervical cancer. This work, which has garnered 15 citations, has directly challenged traditional radical hysterectomy paradigms, offering a less invasive alternative that spares women from lifelong side effects. Dr. Frumovitz’s research has had a profound impact on clinical practice, providing robust evidence for a more patient-centered approach. Her dedication to rigorous, prospective trials has established her as a key figure in the shift toward precision surgery in gynecologic oncology, making her a vital resource for students and clinicians seeking to understand modern, evidence-based treatment of cervical cancer.
Research Focus
Key Achievements
Top Papers
- 1